Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 35.84% is 148% above its 5-year average of 14.48%, near the high end of its 5-year range (7.94%–35.84%).
As of the fiscal period ended Tuesday, June 30, 2026. 132.45% above its 12-month average of 15.42%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 35.84%.
DEBT TO ASSETS RATIO
35.84%
DEBT TO ASSETS RATIO AVG TTM
15.42%
DEBT TO ASSETS RATIO AVG 3Y
12.29%
DEBT TO ASSETS RATIO AVG 5Y
14.48%
DEBT TO ASSETS RATIO AVG 10Y
17.76%
DEBT TO ASSETS RATIO AVG 15Y
19.16%
DEBT TO ASSETS RATIO AVG 20Y
19.87%
CURRENT VS TTM AVG
+132.45%
CURRENT VS 3Y AVG
+191.62%
CURRENT VS 5Y AVG
+147.54%
CURRENT VS 10Y AVG
+101.77%
CURRENT VS 15Y AVG
+87.04%
CURRENT VS 20Y AVG
+80.40%
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 462 covered companies
CURRENT VS SECTOR MEDIAN
+32485.84%
vs the sector median at left
BioMarin Pharmaceutical Inc.
Market Cap
$11.12B
Debt to Assets Ratio
35.84%
TTM Avg
15.42%
3Y Avg
12.29%
5Y Avg
14.48%
Market Cap
$11.07B
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.36B
Debt to Assets Ratio
0.11%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.66B
Debt to Assets Ratio
0.33%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.33B
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.00B
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.22B
Debt to Assets Ratio
0.12%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioMarin Pharmaceutical Inc. (BMRN) | $11.12B | 35.84% | 15.42% | 12.29% | 14.48% |
| The Cooper Companies, Inc. (COO)vs › | $11.07B | 0.20% | N/A | N/A | N/A |
| Bio-Techne Corporation (TECH)vs › | $11.36B | 0.11% | N/A | N/A | N/A |
| ImmunityBio, Inc. (IBRX)vs › | $10.87B | 1.29% | N/A | N/A | N/A |
| DaVita Inc. (DVA)vs › | $11.47B | 0.61% | N/A | N/A | N/A |
| Universal Health Services, Inc. (UHS)vs › | $10.66B | 0.33% | N/A | N/A | N/A |
| Globus Medical, Inc. (GMED)vs › | $10.33B | 0.02% | N/A | N/A | N/A |
| Encompass Health Corporation (EHC)vs › | $12.00B | 0.38% | N/A | N/A | N/A |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.22B | 0.12% | N/A | N/A | N/A |
| Molina Healthcare, Inc. (MOH)vs › | $10.13B | 0.25% | N/A | N/A | N/A |
Debt/Assets
35.8%
Debt/Equity
0.66
Current Ratio
2.39
Interest Coverage
49.0x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 35.84% |
| 2026-03-31 | 16.76% |
| 2025-12-31 | 8.47% |
| 2025-09-30 | 7.94% |
| 2025-06-30 | 8.10% |
| 2025-03-31 | 8.42% |
| 2024-12-31 | 8.62% |
| 2024-09-30 | 8.80% |
| 2024-06-30 | 15.56% |
| 2024-03-31 | 15.96% |
| 2023-12-31 | 16.02% |
| 2023-09-30 | 16.21% |
| 2023-06-30 | 16.66% |
| 2023-03-31 | 16.99% |
| 2022-12-31 | 17.15% |
| 2022-09-30 | 17.42% |
| 2022-06-30 | 17.76% |
| 2022-03-31 | 17.99% |
| 2021-12-31 | 18.14% |
| 2021-09-30 | 18.20% |
| 2021-06-30 | 18.45% |
| 2021-03-31 | 18.73% |
| 2020-12-31 | 18.59% |
| 2020-09-30 | 23.70% |
| 2020-06-30 | 27.44% |
| 2020-03-31 | 18.27% |
| 2019-12-31 | 18.31% |
| 2019-09-30 | 18.73% |
| 2019-06-30 | 19.33% |
| 2019-03-31 | 19.03% |
| 2018-12-31 | 18.76% |
| 2018-09-30 | 25.57% |
| 2018-06-30 | 25.77% |
| 2018-03-31 | 25.74% |
| 2017-12-31 | 25.35% |
| 2017-09-30 | 25.46% |
| 2017-06-30 | 16.82% |
| 2017-03-31 | 17.54% |
| 2016-12-31 | 16.98% |
| 2016-09-30 | 17.58% |
| 2016-06-30 | 21.71% |
| 2016-03-31 | 18.22% |
| 2015-12-31 | 17.76% |
| 2015-09-30 | 18.42% |
| 2015-06-30 | 18.13% |
| 2015-03-31 | 17.92% |
| 2014-12-31 | 25.97% |
| 2014-09-30 | 26.92% |
| 2014-06-30 | 27.75% |
| 2014-03-31 | 28.26% |
| 2013-12-31 | 29.21% |
| 2013-09-30 | 4.83% |
| 2013-06-30 | 6.86% |
| 2013-03-31 | 6.87% |
| 2012-12-31 | 22.20% |
| 2012-09-30 | 22.22% |
| 2012-06-30 | 22.73% |
| 2012-03-31 | 26.85% |
| 2011-12-31 | 26.68% |
| 2011-09-30 | 26.90% |
| 2011-06-30 | 29.48% |
| 2011-03-31 | 29.86% |
| 2010-12-31 | 29.90% |
| 2010-09-30 | 42.86% |
| 2010-06-30 | 52.89% |
| 2010-03-31 | 54.32% |
| 2009-12-31 | 54.20% |
| 2009-09-30 | 57.18% |
| 2009-06-30 | 58.87% |
| 2009-03-31 | 63.02% |
| 2008-12-31 | 70.43% |
| 2008-09-30 | 57.88% |
| 2008-06-30 | 58.87% |
| 2008-03-31 | 60.81% |
| 2007-12-31 | 61.78% |
| 2007-09-30 | 72.17% |
| 2007-06-30 | 73.11% |
| 2007-03-31 | 54.97% |
| 2006-12-31 | 49.79% |
| 2006-09-30 | 64.20% |
| 2006-06-30 | 79.80% |
| 2006-03-31 | 80.88% |
| 2005-12-31 | 114.83% |
| 2005-09-30 | 108.28% |
| 2005-06-30 | 136.39% |
| 2005-03-31 | 93.77% |
| 2004-12-31 | 116.26% |
| 2004-09-30 | 86.73% |
| 2004-06-30 | 53.83% |
| 2004-03-31 | 52.24% |
| 2003-12-31 | 48.76% |
| 2003-09-30 | 43.95% |
| 2003-06-30 | 40.80% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | 2.28% |
